Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8875 |
High Similarity |
NPD37 |
Approved |
0.8788 |
High Similarity |
NPD6232 |
Discontinued |
0.8743 |
High Similarity |
NPD7473 |
Discontinued |
0.8712 |
High Similarity |
NPD4967 |
Phase 2 |
0.8712 |
High Similarity |
NPD4965 |
Approved |
0.8712 |
High Similarity |
NPD4966 |
Approved |
0.858 |
High Similarity |
NPD3818 |
Discontinued |
0.8494 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8314 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8284 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8266 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8256 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8229 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8221 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8171 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8161 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8095 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8081 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8047 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8011 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7966 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7956 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7927 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7869 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD919 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.772 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7714 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.768 |
Intermediate Similarity |
NPD8313 |
Approved |
0.768 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7674 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7665 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7574 |
Intermediate Similarity |
NPD920 |
Approved |
0.7572 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7554 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD1243 |
Approved |
0.747 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7469 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7461 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7446 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7435 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7416 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7409 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7409 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7362 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7337 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7321 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD943 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7282 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7245 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7245 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7236 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7236 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7176 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7157 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7136 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7126 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1283 |
Approved |
0.712 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6386 |
Approved |
0.6988 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD1613 |
Approved |
0.697 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2313 |
Discontinued |
0.697 |
Remote Similarity |
NPD3764 |
Approved |
0.6962 |
Remote Similarity |
NPD9268 |
Approved |
0.6951 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.695 |
Remote Similarity |
NPD7999 |
Approved |
0.6948 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6941 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6937 |
Remote Similarity |
NPD1281 |
Approved |
0.6919 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD7584 |
Approved |
0.6907 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6907
|
Remote Similarity |
NPD6212 |
Phase 3 |